Advertisement

HIV/AIDS

HIV/AIDS

HIV and ID Observations Blog

Should Antibiotics Be Part of End-of-Life Care? Free

Antibiotics often remain an option to the very end — but, Paul Sax asks, to what end? Take the poll in HIV and ID Observations.

Guideline Watch

Prevention and Control of Seasonal Influenza

An update to the recommendations for 2013–2014

Drug Watch

Dolutegravir

The FDA has approved the integrase inhibitor dolutegravir for treatment of HIV infection, in combination with other antiretrovirals.